NDC Package 71335-2109-3 Doxycycline

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71335-2109-3
Package Description:
20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Doxycycline
Usage Information:
To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline tablets, USP and other antibacterial drugs, doxycycline tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.Doxycycline Tablets, USP are indicated for the treatment of the following infections:     Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae.     Respiratory tract infections caused by Mycoplasma pneumoniae.     Lymphogranuloma venereum caused by Chlamydia trachomatis.     Psittacosis (ornithosis) caused by Chlamydophila psittaci.     Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence.     Inclusion conjunctivitis caused by Chlamydia trachomatis.     Uncomplicated urethral, endocervical or rectal infections in adults caused by Chlamydia trachomatis.     Nongonococcal urethritis caused by Ureaplasma urealyticum.     Relapsing fever due to Borrelia recurrentis.Doxycycline Tablets, USP are also indicated for the treatment of infections caused by the following gram-negative microorganisms:     Chancroid caused by Haemophilus ducreyi.     Plague due to Yersinia pestis.     Tularemia due to Francisella tularensis.     Cholera caused by Vibrio cholerae.     Campylobacter fetus infections caused by Campylobacter fetus.     Brucellosis due to Brucella species (in conjunction with streptomycin).     Bartonellosis due to Bartonella bacilliformis.     Granuloma inguinale caused by Klebsiella granulomatis.Because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline, culture and susceptibility testing are recommended.Doxycycline Tablets, USP are indicated for treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug:     Escherichia coli     Enterobacter aerogenes     Shigella species     Acinetobacter species     Respiratory tract infections caused by Haemophilus influenzae.     Respiratory tract and urinary tract infections caused by Klebsiella species.Doxycycline Tablets, USP are indicated for treatment of infections caused by the following gram-positive microorganisms, when bacteriologic testing indicates appropriate susceptibility to the drug:     Upper respiratory infections caused by Streptococcus pneumoniae.     Anthrax due to Bacillus anthracis, including inhalational anthrax (post-exposure); to reduce the incidence or progression of disease following exposure to     aerosolized Bacillus anthracis.When penicillin is contraindicated, doxycycline is an alternative drug in the treatment of the following infections:     Uncomplicated gonorrhea caused by Neisseria gonorrhoeae.     Syphilis caused by Treponema pallidum subspecies pertenue. Yaws caused by Treponema pertenue.  Listeriosis due to Listeria monocytogenes. Vincent's infection caused by Fusobacterium fusiforme.Actinomycosis caused by Actinomyces israelii.Infections caused by Clostridium species.In acute intestinal amebiasis, doxycycline may be a useful adjunct to amebicides.In severe acne, doxycycline may be useful adjunctive therapy.
11-Digit NDC Billing Format:
71335210903
Labeler Name:
Bryant Ranch Prepack
Sample Package:
No
FDA Application Number:
ANDA065285
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
12-08-2005
End Marketing Date:
08-26-2024
Listing Expiration Date:
08-26-2024
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
71335-2109-02 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-130 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-214 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-412 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-540 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-610 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-750 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-821 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
71335-2109-960 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 71335-2109-3?

The NDC Packaged Code 71335-2109-3 is assigned to a package of 20 tablet, film coated in 1 bottle, plastic of Doxycycline, labeled by Bryant Ranch Prepack. The product's dosage form is and is administered via form.

Is NDC 71335-2109 included in the NDC Directory?

No, Doxycycline with product code 71335-2109 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Bryant Ranch Prepack on December 08, 2005 and its listing in the NDC Directory is set to expire on August 26, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 71335-2109-3?

The 11-digit format is 71335210903. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-171335-2109-35-4-271335-2109-03